Myriam Heiman, a renowned molecular neurobiologist and geneticist, has been appointed as the new director of MIT's Picower Institute for Learning and Memory, effective July 1. This appointment marks a significant transition for the institute, as Heiman takes over from Li-Huei Tsai, who has led the institute for 16 years. Heiman's expertise lies in studying neurodegenerative diseases affecting the brain's basal ganglia, including Huntington's and Parkinson's diseases. Her research employs cutting-edge techniques, such as single-cell genomics and her own invention, translating ribosome affinity purification, to unravel the molecular changes leading to cell death in these diseases.
Heiman's appointment is a testament to her exceptional scientific contributions and leadership abilities. Nergis Mavalvala, dean of the MIT School of Science, praises her as an "extraordinary scientist" and a "proven leader within MIT." Mavalvala further highlights Heiman's research on Huntington's disease, which has provided "deep insights and sweeping scope."
Heiman's research has not only advanced our understanding of neurodegenerative diseases but also has broader implications. Her work has revealed errant immune responses in neurons and blood vessels, contributing to disease progression. Additionally, her research has explored overlaps between ALS and frontotemporal dementia, identifying potential targets for therapies applicable to both disorders. Heiman's latest research is also shedding light on substance use disorders and schizophrenia.
Heiman's dedication to mentorship and teaching is equally impressive. She has received awards for excellence in graduate and undergraduate mentoring, and her commitment to caring for students has been recognized by MIT's Office of Graduate Education. Beyond her academic achievements, Heiman serves on editorial boards and the scientific advisory board of the Huntington's Disease Foundation, further demonstrating her dedication to advancing research in this field.
In her new role, Heiman expresses humility and enthusiasm, emphasizing her eagerness to support the next generation of transformative research at the Picower Institute. Her appointment is a significant development for the institute and the field of neuroscience, as she takes on the challenge of leading a community dedicated to understanding learning and memory mechanisms and their impact on human health.
